Partner Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History

Partner Investment Management’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,055	Closed	-$430K	–	89
2015 Q2	$430K	Sell	1,055 -433	-29%	-$187K	0.6%	55
2015 Q1	$683K	Buy	1,488 +395	+36%	+$170K	1.03%	40
2014 Q4	$614K	Sell	1,093 -344	-24%	-$195K	0.25%	59
2014 Q3	$753K	Sell	1,437 -224	-13%	-$126K	0.28%	37
2014 Q2	$1.16M	Buy	1,661 +851	+105%	+$396K	0.23%	44
2014 Q1	$375K	Sell	810 -1,199	-60%	-$608K	0.07%	63
2013 Q4	$662K	Buy	+2,009	New	+$555K	0.15%	45

Other funds holding KPTI

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Partner Investment Management's KPTI Position: Q3 2015 in Review

Partner Investment Management sold out of Karyopharm Therapeutics (KPTI) in Q3 2015, closing a stake of 1,055 shares — an estimated $430K sold.

Partner Investment Management first reported a position in KPTI in Q4 2013 and held it in 7 quarters. The position peaked at $1.16M in Q2 2014. 89 funds tracked by Wall St. Rank hold KPTI as of Q3 2015.

Partner Investment Management reported no remaining Karyopharm Therapeutics position as of Q3 2015 after selling out during the quarter.
Partner Investment Management sold 1,055 Karyopharm Therapeutics shares in Q3 2015, an estimated $430K.
Partner Investment Management first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 7 quarters.
Partner Investment Management's Karyopharm Therapeutics position peaked at $1.16M in Q2 2014.
89 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2015.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.